STAT3 and its phosphorylation are involved in HIV-1 tat-induced transactivation of glial fibrillary acidic protein

Current HIV Research

Volumn 13, Issue 1, 2015, Pages 55-63

  Fan, Yan ^a   Timani, Khalid Amine ^a   He, Johnny J ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Astrocytes; Egr 1; GFAP; HIV 1 Tat; P300; STAT3

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; GLIAL FIBRILLARY ACIDIC PROTEIN; STAT3 PROTEIN; TRANSACTIVATOR PROTEIN; STAT3 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL ACTIVATION; CELL PROLIFERATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PLASMID; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TRANSACTIVATION; WESTERN BLOTTING; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TRANSCRIPTION INITIATION;

ASTROCYTES; CELLS, CULTURED; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIV INFECTIONS; HIV-1; HUMANS; PHOSPHORYLATION; STAT3 TRANSCRIPTION FACTOR; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTIONAL ACTIVATION;

EID: 84930972869     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/1570162X13666150121115804     Document Type: Article

References (101)

1. [1] Lipton SA. Treating AIDS dementia. Science. 1997 Jun 13;276(5319):1629-30. PubMed PMID: 9206820. EPub 1997/06/13. eng.
2. [2] Cunningham PH, Smith DG, Satchell C, Cooper DA, Brew B. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. Aids. 2000 Sep 8;14(13):1949-54. PubMed PMID: 10997399.
3. [3] Ellis RJ, Deutsch R, Heaton RK, et al. Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Archives of neurology. 1997 Apr;54(4):416-24. PubMed PMID: 9109743. EPub 1997/04/01. eng.
4. [4] McArthur JC, McClernon DR, Cronin MF, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Annals of neurology. 1997 Nov;42(5):689-98. PubMed PMID: 9392567. EPub 1997/12/10. eng.
5. [5] Anthony IC, Bell JE. The Neuropathology of HIV/AIDS. International review of psychiatry. 2008 Feb;20(1):15-24. PubMed PMID: 18240059.
6. [6] Saito Y, Sharer LR, Epstein LG, et al. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology. 1994;44:474-81.
7. [7] Tornatore C, Chandra R, Berger JR, Major EO. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology. 1994;44:481-7.
8. [8] Saito Y, Sharer LR, Epstein LG, et al. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology. 1994 Mar;44(3 Pt 1):474-81. PubMed PMID: 8145918.
9. [9] Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. Aids. 1999 Jan 14;13(1):1-22. PubMed PMID: 10207540.
10. [10] Messam CA, Major EO. Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue. Journal of neurovirology. 2000 May;6 Suppl 1:S90-4. PubMed PMID: 10871771.
11. [11] Bagasra O, Lavi E, Bobroski L, et al. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. Aids. 1996 Jun;10(6):573-85. PubMed PMID: 8780811.
12. [12] Tornatore C, Nath A, Amemiya K, Major EO. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol. 1991;65:6094-100.
13. [13] Tornatore C, Meyers K, Atwood W, Conant K, Major E. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol. 1994;68:93-102.
14. [14] Liu Y, Liu H, Kim BO, et al. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. Journal of virology. 2004 Apr;78(8):4120-33. PubMed PMID: 15047828. Pubmed Central PMCID: 374297.
15. [15] Sabri F, Tresoldi E, Di Stefano M, et al. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology. 1999 Nov 25;264(2):370-84. PubMed PMID: 10562499.
16. [16] Gorry PR, Ong C, Thorpe J, et al. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Current HIV research. 2003 Oct;1(4):463-73. PubMed PMID: 15049431.
17. [17] Ong CL, Thorpe JC, Gorry PR, et al. Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response. Journal of virology. 2005 Oct;79(20):12763-72. PubMed PMID: 16188979. Pubmed Central PMCID: 1235869.
18. [18] Carroll-Anzinger D, Al-Harthi L. Gamma interferon primes productive human immunodeficiency virus infection in astrocytes. Journal of virology. 2006 Jan;80(1):541-4. PubMed PMID: 16352578. Pubmed Central PMCID: 1317538.
19. [19] Carroll-Anzinger D, Kumar A, Adarichev V, Kashanchi F, Al-Harthi L. Human immunodeficiency virus-restricted replication in astrocytes and the ability of gamma interferon to modulate this restriction are regulated by a downstream effector of the Wnt signaling pathway. Journal of virology. 2007 Jun;81(11):5864-71. PubMed PMID: 17392368. Pubmed Central PMCID: 1900315.
20. [20] Rossi A, Mukerjee R, Ferrante P, Khalili K, Amini S, Sawaya BE. Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes. The Journal of general virology. 2006 Jun;87(Pt 6):1613-23. PubMed PMID: 16690926.
21. [21] Gorry P, Purcell D, Howard J, McPhee D. Restricted HIV-1 infection of human astrocytes: potential role of nef in the regulation of virus replication. Journal of neurovirology. 1998 Aug;4(4):377-86. PubMed PMID: 9718129.
22. [22] Gorry PR, Howard JL, Churchill MJ, et al. Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev. Journal of virology. 1999 Jan;73(1):352-61. PubMed PMID: 9847339. Pubmed Central PMCID: 103840.
23. [23] Ludwig E, Silberstein FC, van Empel J, et al. Diminished revmediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes. Journal of virology. 1999 Oct;73(10):8279-89. PubMed PMID: 10482578. Pubmed Central PMCID: 112845.
24. [24] Li J, Liu Y, Kim BO, He JJ. Direct participation of Sam68, the 68-kilodalton Src-associated protein in mitosis, in the CRM1-mediated Rev nuclear export pathway. Journal of virology. 2002 Aug;76(16):8374-82. PubMed PMID: 12134041. Pubmed Central PMCID: 155124.
25. [25] Li J, Liu Y, Park IW, He JJ. Expression of exogenous Sam68, the 68-kilodalton SRC-associated protein in mitosis, is able to alleviate impaired Rev function in astrocytes. Journal of virology. 2002 May;76(9):4526-35. PubMed PMID: 11932418. Pubmed Central PMCID: 155096.
26. [26] Clapham PR, Weber JN, Whitby D, et al. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature. 1989 Jan 26;337(6205):368-70. PubMed PMID: 2536142.
27. [27] Williams KC, Hickey WF. Traffic of lymphocytes into the CNS during inflammation and HIV infection. Journal of neuro-AIDS. 1996;1(1):31-55. PubMed PMID: 16873154.
28. [28] Nottet HS, Persidsky Y, Sasseville VG, et al. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. Journal of immunology. 1996 Feb 1;156(3):1284-95. PubMed PMID: 8558009.
29. [29] Persidsky Y, Stins M, Way D, et al. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. Journal of immunology. 1997 Apr 1;158(7):3499-510. PubMed PMID: 9120312.
30. [30] Kibayashi K, Mastri AR, Hirsch CS. Neuropathology of human immunodeficiency virus infection at different disease stages. Human pathology. 1996 Jul;27(7):637-42. PubMed PMID: 8698305.
31. [31] Smith TW, DeGirolami U, Henin D, Bolgert F, Hauw JJ. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. Journal of neuropathology and experimental neurology. 1990 Jul;49(4):357-70. PubMed PMID: 2362185.
32. [32] Nath A, Hartloper V, Furer M, Fowke KR. Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. Journal of neuropathology and experimental neurology. 1995 May;54(3):320-30. PubMed PMID: 7745431.
33. [33] Lokensgard JR, Gekker G, Ehrlich LC, Hu S, Chao CC, Peterson PK. Proinflammatory cytokines inhibit HIV-1(SF162) expression in acutely infected human brain cell cultures. Journal of immunology. 1997 Mar 1;158(5):2449-55. PubMed PMID: 9036996.
34. [34] Eddleston M, Mucke L. Molecular profile of reactive astrocytes--implications for their role in neurologic disease. Neuroscience. 1993 May;54(1):15-36. PubMed PMID: 8515840.
35. [35] Mennerick S, Zorumski CF. Glial contributions to excitatory neurotransmission in cultured hippocampal cells. Nature. 1994 Mar 3;368(6466):59-62. PubMed PMID: 7906399.
36. [36] Charles AC, Merrill JE, Dirksen ER, Sanderson MJ. Intercellular signaling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate. Neuron. 1991 Jun;6(6):983-92. PubMed PMID: 1675864.
37. [37] Schmidtmayerova H, Nottet HS, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, et al. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proceedings of the National Academy of Sciences of the United States of America. 1996 Jan 23;93(2):700-4. PubMed PMID: 8570619. Pubmed Central PMCID: 40116.
38. [38] Conant K, Garzino-Demo A, Nath A, et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proceedings of the National Academy of Sciences of the United States of America. 1998 Mar 17;95(6):3117-21. PubMed PMID: 9501225. Pubmed Central PMCID: 19704. EPub 1998/04/18. eng.
39. [39] Vitkovic L, Chatham JJ, da Cunha A. Distinct expressions of three cytokines by IL-1-stimulated astrocytes in vitro and in AIDS brain. Brain, behavior, and immunity. 1995 Dec;9(4):378-88. PubMed PMID: 8903854.
40. [40] Rho MB, Wesselingh S, Glass JD, et al. A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia. Brain, behavior, and immunity. 1995 Dec;9(4):366-77. PubMed PMID: 8903853.
41. [41] Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, Lee SC. Reactive nitrogen intermediates in human neuropathology: an overview. Developmental neuroscience. 1994;16(3-4):152-61. PubMed PMID: 7535680.
42. [42] Hu J, Ferreira A, Van Eldik LJ. S100beta induces neuronal cell death through nitric oxide release from astrocytes. Journal of neurochemistry. 1997 Dec;69(6):2294-301. PubMed PMID: 9375660.
43. [43] Hernandez M, Bayon Y, Sanchez Crespo M, Nieto ML. Thrombin produces phosphorylation of cytosolic phospholipase A2 by a mitogen-activated protein kinase kinase-independent mechanism in the human astrocytoma cell line 1321N1. The Biochemical journal. 1997 Nov 15;328 (Pt 1):263-9. PubMed PMID: 9359863. Pubmed Central PMCID: 1218916.
44. [44] Desplats P, Dumaop W, Smith D, et al. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology. 2013 Apr 9;80(15):1415-23. PubMed PMID: 23486877. Pubmed Central PMCID: 3662272.
45. [45] Kingsman SM, Kingsman AJ. The regulation of human immunodeficiency virus type-1 gene expression. European journal of biochemistry/FEBS. 1996 Sep 15;240(3):491-507. PubMed PMID: 8856047.
46. [46] Li W, Li G, Steiner J, Nath A. Role of Tat protein in HIV neuropathogenesis. Neurotoxicity research. 2009 Oct;16(3):205-20. PubMed PMID: 19526283.
47. [47] Caporello E, Nath A, Slevin J, et al. The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load. Journal of neurochemistry. 2006 Jul;98(1):146-55. PubMed PMID: 16805804.
48. [48] Norman JP, Perry SW, Kasischke KA, Volsky DJ, Gelbard HA. HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons. Journal of immunology. 2007 Jan 15;178(2):869-76. PubMed PMID: 17202348.
49. [49] Jones M, Olafson K, Del Bigio MR, Peeling J, Nath A. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. Journal of neuropathology and experimental neurology. 1998 Jun;57(6):563-70. PubMed PMID: 9630236.
50. [50] Kim BO, Liu Y, Ruan Y, Xu ZC, Schantz L, He JJ. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. The American journal of pathology. 2003 May;162(5):1693-707. PubMed PMID: 12707054. Pubmed Central PMCID: 1851199.
51. [51] Nath A, Psooy K, Martin C, et al. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. Journal of virology. 1996 Mar;70(3):1475-80. PubMed PMID: 8627665. Pubmed Central PMCID: 189968.
52. [52] New DR, Ma M, Epstein LG, Nath A, Gelbard HA. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. Journal of neurovirology. 1997 Apr;3(2):168-73. PubMed PMID: 9111179.
53. [53] Ranki A, Nyberg M, Ovod V, et al. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. Aids. 1995 Sep;9(9):1001-8. PubMed PMID: 8527071.
54. [54] Ensoli B, Buonaguro L, Barillari G, et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. Journal of virology. 1993 Jan;67(1):277-87. PubMed PMID: 8416373. Pubmed Central PMCID: 237361.
55. [55] Kolson DL, Collman R, Hrin R, et al. Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and transactivation. The Journal of general virology. 1994 Aug;75 (Pt 8):1927-34. PubMed PMID: 8046394.
56. [56] Ma M, Nath A. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. Journal of virology. 1997 Mar;71(3):2495-9. PubMed PMID: 9032389. Pubmed Central PMCID: 191362.
57. [57] Hudson L, Liu J, Nath A, et al. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. Journal of neurovirology. 2000;6(2):145-55.
58. [58] Chauhan A, Turchan J, Pocernich C, et al. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J Biol Chem. 2003;278(15):13512-9.
59. [59] Johnson TP, Patel K, Johnson KR, et al. Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proceedings of the National Academy of Sciences of the United States of America. 2013 Aug 13;110(33):13588-93. PubMed PMID: 23898208. Pubmed Central PMCID: 3746932.
60. [60] Atwood WJ, Tornatore CS, Meyers K, Major EO. HIV-1 mRNA transcripts from persistently infected human fetal astrocytes. Annals of the New York Academy of Sciences. 1993 Oct 29;693:324-5. PubMed PMID: 8267293.
61. [61] Benelli R, Barbero A, Ferrini S, et al. Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: implications for Tat-mediated pathogenesis. The Journal of infectious diseases. 2000 Dec;182(6):1643-51. PubMed PMID: 11069235.
62. [62] Park IW, Wang JF, Groopman JE. HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. Blood. 2001 Jan 15;97(2):352-8. PubMed PMID: 11154208.
63. Eugenin E, King J, Nath A, et al. HIV-tat induces formation of an LRP–PSD-95– NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytes. Proceedings of the National Academy of Sciences of the United States of America. 2007 (104):3438-43.
64. [64] Chen P, Mayne M, Power C, Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J Biol Chem. 1997 Sep 5;272(36):22385-8. PubMed PMID: 9278385.
65. [65] Cheng J, Nath A, Knudsen B, et al. Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein. Neuroscience. 1998 Jan;82(1):97-106. PubMed PMID: 9483506.
66. [66] Cupp C, Taylor JP, Khalili K, Amini S. Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene. 1993 Aug;8(8):2231-6. PubMed PMID: 8336945.
67. [67] Kolson DL, Buchhalter J, Collman R, et al. HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS research and human retroviruses. 1993 Jul;9(7):677-85. PubMed PMID: 8369172.
68. [68] Chen X, Hui L, Geiger NH, Haughey NJ, Geiger JD. Endolysosome involvement in HIV-1 transactivator proteininduced neuronal amyloid beta production. Neurobiology of aging. 2013 Oct;34(10):2370-8. PubMed PMID: 23673310. Pubmed Central PMCID: 3706576.
69. [69] Nath A, Conant K, Chen P, Scott C, Major EO. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem. 1999 Jun 11;274(24):17098-102. PubMed PMID: 10358063. EPub 1999/06/08. eng.
70. [70] El-Hage N, Gurwell JA, Singh IN, Knapp PE, Nath A, Hauser KF. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia. 2005 Apr 15;50(2):91-106. PubMed PMID: 15630704. EPub 2005/01/05. eng.
71. [71] Williams R, Yao H, Dhillon NK, Buch SJ. HIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes. PLoS One. 2009;4(5):e5709. PubMed PMID: 19479051. Pubmed Central PMCID: 2684622. EPub 2009/05/30. eng.
72. [72] Zhou BY, He JJ. Proliferation inhibition of astrocytes, neurons, and non-glial cells by HIV-1 Tat protein. Neuroscience Letters. 2004;359:155-8.
73. [73] Zhou BY, Liu Y, Kim B, Xiao Y, He JJ. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Molecular and cellular neurosciences. 2004 Nov;27(3):296-305. PubMed PMID: 15519244.
74. [74] Zhou BY, He JJ. Proliferation inhibition of astrocytes, neurons, and non-glial cells by intracellularly expressed human immunodeficiency virus type 1 (HIV-1) Tat protein. Neurosci Lett. 2004 Apr 15;359(3):155-8. PubMed PMID: 15050687. EPub 2004/03/31. eng.
75. [75] Zou W, Kim BO, Zhou BY, Liu Y, Messing A, He JJ. Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein. The American journal of pathology. 2007 Dec;171(6):1923-35. PubMed PMID: 18055541. Pubmed Central PMCID: 2111115. EPub 2007/12/07. eng.
76. [76] Fitting S, Ignatowska-Jankowska BM, Bull C, et al. Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice. Biological psychiatry. 2013 Mar 1;73(5):443-53. PubMed PMID: 23218253. Pubmed Central PMCID: 3570635.
77. [77] Carey AN, Liu X, Mintzopoulos D, et al. Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions. Progress in neuro-psychopharmacology & biological psychiatry. 2013 Jun 3;43:49-54. PubMed PMID: 23269344. Pubmed Central PMCID: 3612135.
78. [78] Carey AN, Sypek EI, Singh HD, Kaufman MJ, McLaughlin JP. Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behavioural brain research. 2012 Apr 1;229(1):48-56. PubMed PMID: 22197678. Pubmed Central PMCID: 3580389.
79. [79] Paris JJ, Singh HD, Ganno ML, Jackson P, McLaughlin JP. Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat. Psychopharmacology. 2013 Dec 19. PubMed PMID: 24352568.
80. [80] Fan Y, Zou W, Green LA, Kim BO, He JJ. Activation of Egr-1 expression in astrocytes by HIV-1 Tat: new insights into astrocytemediated Tat neurotoxicity. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology. 2011 Mar;6(1):121-9. PubMed PMID: 20414733. Pubmed Central PMCID: 3056338.
81. [81] Kim BO, Liu Y, Zhou BY, He JJ. Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cellderived and chemokine-related cytokine) expression by HIV-1 Tat protein. Journal of immunology. 2004 Feb 1;172(3):1888-95. PubMed PMID: 14734774.
82. [82] Yu J, de Belle I, Liang H, Adamson ED. Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Molecular cell. 2004 Jul 2;15(1):83-94. PubMed PMID: 15225550. EPub 2004/07/01. eng.
83. [83] Bonni A, Sun Y, Nadal-Vicens M, et al. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science. 1997 Oct 17;278(5337):477-83. PubMed PMID: 9334309. EPub 1997/10/23. eng.
84. [84] Nakashima K, Wiese S, Yanagisawa M, et al. Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1999 Jul 1;19(13):5429-34. PubMed PMID: 10377352. EPub 1999/06/23. eng.
85. [85] Weihe E, Nohr D, Sharer L, Murray E, Rausch D, Eiden L. Cortical astrocytosis in juvenile rhesus monkeys infected with simian immunodeficiency virus. Neuroreport. 1993 Mar;4(3):263-6. PubMed PMID: 8477048.
86. [86] Zou W, Wang Z, Liu Y, Fan Y, Zhou BY, Yang XF, et al. Involvement of p300 in constitutive and HIV-1 Tat-activated expression of glial fibrillary acidic protein in astrocytes. Glia. 2010 Oct;58(13):1640-8. PubMed PMID: 20578042. Pubmed Central PMCID: 2919602.
87. [87] Mechoulam H, Pierce EA. Expression and activation of STAT3 in ischemia-induced retinopathy. Investigative ophthalmology & visual science. 2005 Dec;46(12):4409-16. PubMed PMID: 16303927.
88. [88] Teng CB, Diao HL, Ma XH, Xu LB, Yang ZM. Differential expression and activation of Stat3 during mouse embryo implantation and decidualization. Molecular reproduction and development. 2004 Sep;69(1):1-10. PubMed PMID: 15278897.
89. [89] Liang XH, Deng WB, Li M, et al. Egr1 protein acts downstream of estrogen-leukemia inhibitory factor (LIF)-STAT3 pathway and plays a role during implantation through targeting Wnt4. J Biol Chem. 2014 Aug 22;289(34):23534-45. PubMed PMID: 25012664. Pubmed Central PMCID: 4156077.
90. [90] Corcoran RB, Contino G, Deshpande V, et al. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer research. 2011 Jul 15;71(14):5020-9. PubMed PMID: 21586612. Pubmed Central PMCID: 3693754.
91. [91] Hardee J, Ouyang Z, Zhang Y, Kundaje A, Lacroute P, Snyder M. STAT3 targets suggest mechanisms of aggressive tumorigenesis in diffuse large B-cell lymphoma. G3. 2013 Dec;3(12):2173-85. PubMed PMID: 24142927. Pubmed Central PMCID: 3852380.
92. [92] Yin ZJ, Jin FG, Liu TG, Fu EQ, Xie YH, Sun RL. Overexpression of STAT3 potentiates growth, survival, and radioresistance of nonsmall-cell lung cancer (NSCLC) cells. The Journal of surgical research. 2011 Dec;171(2):675-83. PubMed PMID: 20605584. EPub 2010/07/08. eng.
93. [93] Chatterjee M, Jain S, Stuhmer T, et al. STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survival. Blood. 2007 Jan 15;109(2):720-8. PubMed PMID: 17003370. EPub 2006/09/28. eng.
94. [94] Revest JM, Di Blasi F, Kitchener P, et al. The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids. Nature neuroscience. 2005 May;8(5):664-72. PubMed PMID: 15834420.
95. [95] Chu L, Wang T, Hu Y, Gu Y, Su Z, Jiang H. Activation of Egr-1 in human lung epithelial cells exposed to silica through MAPKs signaling pathways. PLoS One. 2013;8(7):e68943. PubMed PMID: 23874821. Pubmed Central PMCID: 3715534.
96. [96] Liang HE, Hsueh YP, Wu CC, Hsu SC, Han SH, Lai MZ. Atypical signaling defects prevent IL-2 gene expression in lpr/lpr CD4-CD8-cells. Journal of biomedical science. 1998 Jul-Aug;5(4):297-304. PubMed PMID: 9691223. EPub 1998/08/06. eng.
97. [97] Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 2000 May 15;19(21):2548-56. PubMed PMID: 10851053. EPub 2000/06/13. eng.
98. [98] Gregg J, Fraizer G. Transcriptional Regulation of EGR1 by EGF and the ERK Signaling Pathway in Prostate Cancer Cells. Genes & cancer. 2011 Sep;2(9):900-9. PubMed PMID: 22593802. Pubmed Central PMCID: 3352154.
99. [99] Dabir S, Kluge A, Aziz MA, Houghton JA, Dowlati A. Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors. Cancer biology & therapy. 2011 Jul 15;12(2):139-51. PubMed PMID: 21532337. Pubmed Central PMCID: 3154286.
100. [100] Schiavone D, Avalle L, Dewilde S, Poli V. The immediate early genes Fos and Egr1 become STAT1 transcriptional targets in the absence of STAT3. FEBS letters. 2011 Aug 4;585(15):2455-60. PubMed PMID: 21723864.
101. [101] Nakashima K, Yanagisawa M, Arakawa H, et al. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science. 1999 Apr 16;284(5413):479-82. PubMed PMID: 10205054.